Skip to main content

Researcher receives more than $1.7 million grant to help patients living with triple-negative breast cancer

January 17, 2020

Juliane Nguyen, Pharm.D., Ph.D., is on a mission to develop the next generation of safe and effective biotherapeutics for life-threatening diseases such as triple-negative breast cancer. Nguyen, an associate professor in UNC Eshelman School of Pharmacy’s Division of Pharmacoengineering and Molecular Pharmaceutics, said while some patients diagnosed with triple-negative breast cancer do well if they are showing early responses to chemotherapy, the overall prognosis for women with the aggressive cancer remains poor. “In contrast to other breast cancer subtypes, patients are more likely to have residual disease after primary therapy and recurrences and metastases occur early,” Nguyen said. “Because no … Read more


Researcher’s postdoc work on micronutrients published in Science journal

December 18, 2019

Aaron Anselmo, Ph.D., is looking for new ways to deliver micronutrients, such as vitamins and minerals, to people across the world. “Currently a lot of different foods are fortified with micronutrients in the developing world, but some of these fortification approaches don’t address the end use of the product,” he said. “For example, cooking at high temperatures and long times can result in degradation of the fortified micronutrient which then won’t be absorbed by the body.” Anselmo is currently an assistant professor at the UNC Eshelman School of Pharmacy’s Division of Pharmacoengineering and Molecular Pharmaceutics. His lab conducts research on therapeutic … Read more